• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
E25
Click for more information
0.00% 33.5¢

ELEMENT 25 LIMITED - Corporate Spotlight

Market Cap $73.67M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Industrial Metals & Minerals

Element 25 Limited is an Australia-based mineral exploration company. The Company is the... Element 25 Limited is an Australia-based mineral exploration company. The Company is the operator of the Butcherbird Manganese Project (Project), which hosts onshore manganese resources with Joint Ore Reserve Committee (JORC) resources of more than 260 million tons (Mt) of manganese ore. The Project is located approximately 1,050 kilometers (kms) north of Perth and over 130 kilometers south of Newman in the Pilbara region of Western Australia. The Company is developing capabilities by producing high-purity manganese sulphate monohydrate (HPMSM) for sustainable lithium-ion battery cathode manufacture, with several production facilities planned. The Company’s other project include Lake Johnston Lithium Project, which is located approximately 500km east of Perth, Western Australia.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
33.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $73.67M
Open High Low Value Volume
33.5¢ 34.0¢ 31.0¢ $236.8K 727.7K

Buyers (Bids)

No. Vol. Price($)
1 5000 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 21201 1
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
Last
33.5¢ 		  Change
0.000 ( 3.30 %)
Open High Low Volume
33.5¢ 34.0¢ 32.0¢ 219221
Last updated 14.35pm 01/10/2024 ?
E25 (ASX) Chart

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Iress runs 'hot' for Wealth Within's stock tips Financial services software play Iress (ASX:IRE) is the HotCopper Hot Stock tip this week from Wealth Within's chief analyst Dale Gillham and senior analyst Fil Tortevski.
Failure to report prompts ASX to impose multiple company suspensions The ASX today told more than 20 companies across many sectors that it would be imposing suspensions on them
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.